Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Intestinal2466 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A12021 | 30641412 | Mol Immunol | New Aspect of Liver IL-17+γδ T Cells. | 2019 | Details |
| A12040 | 30628563 | Proc Nutr Soc | Contribution of the gut microbiota to the regulation of host metabolism and energy balance: a focus on the gut-liver axis. | 2019 | Details |
| A12058 | 30619992 | Hepatol Commun | Gut Microbial Metabolism and Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A12061 | 30618824 | Front Physiol | Intestinal Microbiota Modulation in Obesity-Related Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A12063 | 30618733 | Front Pharmacol | Geniposide and Chlorogenic Acid Combination Ameliorates Non-alcoholic Steatohepatitis Involving the Protection on the Gut Barrier Function in Mouse Induced by High-Fat Diet. | 2018 | Details |
| A12068 | 30616887 | Biochem Biophys Res Commun | Gut dysbiosis-derived exosomes trigger hepatic steatosis by transiting HMGB1 from intestinal to liver in mice. | 2019 | Details |
| A12082 | 30609782 | Nutrients | Beneficial Effects of Vitamin D Treatment in an Obese Mouse Model of Non-Alcoholic Steatohepatitis. | 2019 | Details |
| A12092 | 30605883 | Redox Biol | Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function. | 2018 | Details |
| A12093 | 30605818 | Environ Pollut | Effects of triphenyl phosphate exposure during fetal development on obesity and metabolic dysfunctions in adult mice: Impaired lipid metabolism and intestinal dysbiosis. | 2018 | Details |
| A12095 | 30605011 | Am J Physiol Gastrointest Liver Physiol | Intestinal TGR5 agonism improves hepatic steatosis and insulin sensitivity in Western diet-fed mice. | 2019 | Details |
| A12114 | 30596786 | PLoS One | Protective effects of Bacillus probiotics against high-fat diet-induced metabolic disorders in mice. | 2018 | Details |
| A12117 | 32864300 | Curr Pharmacol Rep | Dietary Additives and Supplements Revisited: The Fewer, the Safer for Liver and Gut Health. | 2019 | Details |
| A12126 | 30591521 | EMBO Mol Med | The role of the microbiome in NAFLD and NASH. | 2019 | Details |
| A12145 | 30582898 | Biochem Pharmacol | Developments in bile salt based therapies: A critical overview. | 2018 | Details |
| A12151 | 30580671 | Lab Anim | The role of gut microbiota in intestinal and liver diseases. | 2018 | Details |
| A12152 | 30580553 | Crit Rev Food Sci Nutr | n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review. | 2018 | Details |
| A12159 | 30578461 | Adv Exp Med Biol | Fighting Fatty Liver Diseases with Nutritional Interventions, Probiotics, Symbiotics, and Fecal Microbiota Transplantation (FMT). | 2019 | Details |
| A12163 | 30577415 | Int J Mol Sci | Diet-Independent Correlations between Bacteria and Dysfunction of Gut, Adipose Tissue, and Liver: A Comprehensive Microbiota Analysis in Feces and Mucosa of the Ileum and Colon in Obese Mice with NAFLD. | 2018 | Details |
| A12175 | 30574320 | United European Gastroenterol J | Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease. | 2018 | Details |
| A12200 | 30564426 | R Soc Open Sci | Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy. | 2018 | Details |
| A12204 | 30563142 | Molecules | Modulation of Gut Microbiota by Lonicera caerulea L. Berry Polyphenols in a Mouse Model of Fatty Liver Induced by High Fat Diet. | 2018 | Details |
| A12237 | 30551665 | Children (Basel) | Pediatric Fatty Liver and Obesity: Not Always Justa Matter of Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A12256 | 30544653 | Int J Mol Sci | miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis. | 2018 | Details |
| A12262 | 30525304 | Mol Nutr Food Res | SIRT3 Deficiency Promotes High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Correlation with Impaired Intestinal Permeability through Gut Microbial Dysbiosis. | 2018 | Details |
| A12278 | 30537110 | Mol Nutr Food Res | Combination of Whole Grapeseed Flour and Newly Isolated Kefir Lactic Acid Bacteria Reduces High-Fat-Induced Hepatic Steatosis. | 2018 | Details |
| A12291 | 30527903 | Hepatobiliary Pancreat Dis Int | Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis. | 2018 | Details |
| A12293 | 30526624 | J Transl Med | L-Fucose ameliorates high-fat diet-induced obesity and hepatic steatosis in mice. | 2018 | Details |
| A12294 | 30522122 | Cell Physiol Biochem | Microbial Intervention as a Novel Target in Treatment of Non-Alcoholic Fatty Liver Disease Progression. | 2018 | Details |
| A12305 | 30507741 | Transplantation | Functional Microbiomics in Liver Transplantation: Identifying Novel Targets for Improving Allograft Outcomes. | 2019 | Details |
| A12335 | 30510243 | Exp Mol Med | Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression. | 2018 | Details |
| A12336 | 30509561 | J Formos Med Assoc | Gut microbiota and pediatric obesity/non-alcoholic fatty liver disease. | 2018 | Details |
| A12373 | 30482910 | Nat Rev Gastroenterol Hepatol | The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2019 | Details |
| A12442 | 30454829 | Clin Liver Dis | Will Studies in Nonalcoholic Steatohepatitis Help Manage Alcoholic Steatohepatitis? | 2019 | Details |
| A12447 | 30453950 | BMC Complement Altern Med | Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: a randomized clinical trial (PROSIR). | 2018 | Details |
| A12449 | 30453660 | Nutrients | Gut Permeability Might be Improved by Dietary Fiber in Individuals with Nonalcoholic Fatty Liver Disease (NAFLD) Undergoing Weight Reduction. | 2018 | Details |
| A12459 | 30446669 | Nat Commun | Serotonin signals through a gut-liver axis to regulate hepatic steatosis. | 2018 | Details |
| A12469 | 30443932 | J Cell Biochem | Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics. | 2018 | Details |
| A12503 | 30416839 | Liver Res | Gut microbiota, fatty liver disease, and hepatocellular carcinoma. | 2018 | Details |
| A12515 | 30412872 | Sci Total Environ | Gut microbiota dysbiosis correlates with a low-dose PCB126-induced dyslipidemia and non-alcoholic fatty liver disease. | 2018 | Details |
| A12532 | 30405618 | Front Immunol | Adapted Immune Responses of Myeloid-Derived Cells in Fatty Liver Disease. | 2018 | Details |
| A12557 | 30392210 | Zhonghua Er Ke Za Zhi | [Specific changes of intestinal microflora in children with nonalcoholic fatty liver disease]. | 2018 | Details |
| A12558 | 30392013 | J Gastroenterol | Antimicrobial proteins: intestinal guards to protect against liver disease. | 2018 | Details |
| A12570 | 30387131 | J Cell Physiol | Repression of TXNIP-NLRP3 axis restores intestinal barrier function via inhibition of myeloperoxidase activity and oxidative stress in nonalcoholic steatohepatitis. | 2018 | Details |
| A12583 | 30377993 | J Microbiol | Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics. | 2018 | Details |
| A12604 | 30367045 | Nat Commun | The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD. | 2018 | Details |
| A12609 | 30365236 | Hepatol Res | Combining probiotics and an angiotensin-II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non-alcoholic steatohepatitis. | 2018 | Details |
| A12632 | 30359008 | J Agric Food Chem | Ursolic Acid, a Novel Liver X Receptor α (LXRα) Antagonist Inhibiting Ligand-Induced Nonalcoholic Fatty Liver and Drug-Induced Lipogenesis. | 2018 | Details |
| A12646 | 30351048 | J Agric Food Chem | Oleanolic Acid Inhibits Liver X Receptor Alpha and Pregnane X Receptor to Attenuate Ligand-Induced Lipogenesis. | 2018 | Details |
| A12733 | 30312513 | Liver Int | Potential mechanisms linking gut microbiota and portal hypertension. | 2018 | Details |
| A12746 | 30306296 | Eur J Nutr | Non-alcoholic fatty liver disease and obesity: the role of the gut bacteria. | 2018 | Details |
| A12747 | 30305244 | Biochim Biophys Acta Mol Cell Biol Lipids | Intake of stigmasterol and β-sitosterol alters lipid metabolism and alleviates NAFLD in mice fed a high-fat western-style diet. | 2018 | Details |
| A12756 | 30300287 | Transplantation | Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH. | 2019 | Details |
| A12760 | 30298840 | Nihon Yakurigaku Zasshi | [Gut microbiota and nonalcoholic steatohepatitis]. | 2018 | Details |
| A12768 | 30297615 | Nutrients | Gut Microbiota's Relationship with Liver Disease and Role in Hepatoprotection by Dietary Natural Products and Probiotics. | 2018 | Details |
| A12778 | 30292107 | J Nutr Biochem | Liraglutide modulates gut microbiota and reduces NAFLD in obese mice. | 2018 | Details |
| A12849 | 30257633 | Med J Aust | The gut microbiota: cause and cure of gut diseases. | 2018 | Details |
| A12881 | 30244334 | Curr Gastroenterol Rep | Treatment of NASH with Gastric Bypass. | 2018 | Details |
| A12897 | 30235828 | Nutrients | Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern. | 2018 | Details |
| A12927 | 30222962 | Gastroenterology | Factors Associated With Histologic Response in Adult Patients With Nonalcoholic Steatohepatitis. | 2018 | Details |
| A12971 | 30202815 | Hepatol Commun | Hepatic connexin 32 associates with nonalcoholic fatty liver disease severity. | 2018 | Details |
| A12975 | 30200724 | Zhongguo Zhong Yao Za Zhi | [Effect of traditional Chinese medicine in inhibiting obesity and inflammatory diseases by regulating gut microbiota]. | 2018 | Details |
| A12986 | 30196156 | Clin Gastroenterol Hepatol | Emerging Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease: From Composition to Function. | 2018 | Details |
| A13012 | 30181611 | Nat Rev Gastroenterol Hepatol | Gut adaptation after metabolic surgery and its influences on the brain, liver and cancer. | 2018 | Details |
| A13021 | 30178233 | Front Med | Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota. | 2018 | Details |
| A13024 | 30175608 | Orv Hetil | [The role of gut microbiota in chronic liver diseases, and treatment possibilities]. | 2018 | Details |
| A13028 | 30174213 | Lancet Diabetes Endocrinol | Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. | 2018 | Details |
| A13029 | 30173562 | Expert Opin Biol Ther | Fecal microbiota transplantation: a promising strategy in preventing the progression of non-alcoholic steatohepatitis and improving the anti-cancer immune response. | 2018 | Details |
| A13036 | 30171065 | Gut | Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease. | 2018 | Details |
| A13106 | 30135638 | Cent Eur J Immunol | Changes in the immune system - the key to diagnostics and therapy of patients with non-alcoholic fatty liver disease. | 2018 | Details |
| A13144 | 30117754 | Expert Rev Gastroenterol Hepatol | Unmet needs in pediatric NAFLD research: what do we need to prioritize for the future? | 2018 | Details |
| A13150 | 30113661 | Nutr Rev | Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis. | 2018 | Details |
| A13155 | 30112382 | Biomed Res Int | Volatile Oil of Amomum villosum Inhibits Nonalcoholic Fatty Liver Disease via the Gut-Liver Axis. | 2018 | Details |
| A13164 | 30105660 | Obes Surg | Small Intestinal Length Associates with Serum Triglycerides Before and After LRYGB. | 2018 | Details |
| A13165 | 30105078 | Evid Based Complement Alternat Med | Chaihu-Shugan-San Decoction Modulates Intestinal Microbe Dysbiosis and Alleviates Chronic Metabolic Inflammation in NAFLD Rats via the NLRP3 Inflammasome Pathway. | 2018 | Details |
| A13181 | 30098126 | Diabetes Obes Metab | The effects of dietary supplementation with inulin and inulin-propionate ester on hepatic steatosis in adults with non-alcoholic fatty liver disease. | 2018 | Details |
| A13185 | 30096384 | Life Sci | Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: Attention to the gut-vascular barrier dysfunction. | 2018 | Details |
| A13188 | 30094487 | Curr Atheroscler Rep | Nuts and Cardiovascular Disease Prevention. | 2018 | Details |
| A13205 | 30085339 | Int J Mol Med | Markers of activated inflammatory cells are associated with disease severity and intestinal microbiota in adults with non‑alcoholic fatty liver disease. | 2018 | Details |
| A13278 | 30054551 | Sci Rep | Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxin. | 2018 | Details |
| A13283 | 30051965 | Mol Nutr Food Res | Galactomannan More than Pectin Exacerbates Liver Injury in Mice Fed with High-Fat, High-Cholesterol Diet. | 2018 | Details |
| A13315 | 30036479 | Mol Pharm | Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier. | 2018 | Details |
| A13376 | 30011790 | Int J Mol Sci | New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis. | 2018 | Details |
| A13393 | 30002342 | Nutrients | Celiac Disease and Liver Disorders: From Putative Pathogenesis to Clinical Implications. | 2018 | Details |
| A13411 | 29991872 | World J Gastroenterol | Apoptosis and non-alcoholic fatty liver diseases. | 2018 | Details |
| A13420 | 29987933 | J Agric Food Chem | Pectin Alleviates High Fat (Lard) Diet-Induced Nonalcoholic Fatty Liver Disease in Mice: Possible Role of Short-Chain Fatty Acids and Gut Microbiota Regulated by Pectin. | 2018 | Details |
| A13421 | 29986142 | J Med Chem | Monoacylglycerol Acyltransferase 2 (MGAT2) Inhibitors for the Treatment of Metabolic Diseases and Nonalcoholic Steatohepatitis (NASH). | 2018 | Details |
| A13444 | 29970888 | Nat Rev Gastroenterol Hepatol | Adiposity and gastrointestinal cancers: epidemiology, mechanisms and future directions. | 2018 | Details |
| A13473 | 29956210 | Adv Exp Med Biol | Microbiota, Obesity and NAFLD. | 2018 | Details |
| A13474 | 29956209 | Adv Exp Med Biol | The Influence of Gut Microbial Metabolism on the Development and Progression of Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A13483 | 29955245 | Oxid Med Cell Longev | Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression. | 2018 | Details |
| A13495 | 29948900 | Sci China Life Sci | Characteristics of fecal microbiota in non-alcoholic fatty liver disease patients. | 2018 | Details |
| A13523 | 29931613 | Curr Diab Rep | The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes. | 2018 | Details |
| A13526 | 29930468 | World J Gastroenterol | Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis. | 2018 | Details |
| A13534 | 29926176 | Eur J Nutr | Lack of liver steatosis in germ-free mice following hypercaloric diets. | 2018 | Details |
| A13546 | 29920654 | Clin Exp Immunol | Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASH. | 2018 | Details |
| A13555 | 29913120 | Chem Biol Interact | Impact of diet on irinotecan toxicity in mice. | 2018 | Details |
| A13566 | 29906416 | Gastroenterology | Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis. | 2018 | Details |
| A13567 | 29904722 | Clin Exp Hepatol | Underrated enemy - from nonalcoholic fatty liver disease to cancers of the gastrointestinal tract. | 2018 | Details |
| A13574 | 29902065 | Am J Physiol Gastrointest Liver Physiol | Mesenteric adipose tissue contributes to intestinal barrier integrity and protects against nonalcoholic fatty liver disease in mice. | 2018 | Details |
| A13615 | 29873593 | Metab Syndr Relat Disord | Variation in the Plasma Levels of Polyunsaturated Fatty Acids in Control vis-à-vis Nonalcoholic Fatty Liver Disease Subjects and Its Possible Association with Gut Microbiome. | 2018 | Details |